Suchergebnisse

The subprime crisis and the general crisis of the global financial system in 2008 not only put the globalization process and all that it involves under extreme pressure, but, at least for some, it called the entire system into question. What in spring had seemed unthinkable, at least for those who had ignored Paul Krugman's blogs, suddenly and without warning became hard reality. A credo of today's prominent leaders is that thoroughly considered and internationally effective regulation is needed to address almost all current global challenges, whether they concern global warming, human rights and migration, or international finance. Such regulatory systems will have to pay attention to ethics and morals, which is something that the present collapsed system has failed to do. This book privides insight into the functioning of the global economy, the rotts of the present international financial crisis and the responses of highly distinguished politicians, industrialists and academics. (Quelle: Text Verlagseinband / Verlag)

The progress of medicine is heavily dependent on the progress of science and technology, which in turn depend on costly and risky investment in research and development. In this contribution, based on some concrete examples, new scientific achievements are presented as basis of modern medicine and source of ethical concerns. Addressed are also the role of scientists in coping with safety in ethical concerns as regards hazards of new technologies, costs of R&D investment in drug development and the role of patents in this context. In some detail the legal situation existing at an international and European level as regards exclusions from patentability based on reasons of ethics and morals is presented. A critical appraisal of the case law of the Court of Justice of the European Union as regards patentability of embryonic stem cells is offered.

Regenerative Medizin setzt große Hoffnungen in die Forschung mit humanen embryonalen Stammzellen. Ebenso umstritten wie diese Forschung selbst ist auch die Patentierung von Erfindungen, die sich auf humane embryonale pluripotente Stammzellen beziehen. Sowohl im regulatorischen Bereich wie auch im Bereich der Patentierung gibt es international große Unterschiede. Die Beiträge legen dar und analysieren die aus rechtlicher wie ethischer Sicht komplizierte Rechtslage der Patentierung in diesem Bereich nach dem europäischen Patentrecht und den Patentrechten der VR China, Deutschlands, Frankreichs, Japans, Kanadas, Koreas, Österreichs, der Schweiz, der USA und des Vereinigten Königreiches. Jedem an dieser Materie Interessierten bieten sie eine wertvolle Orientierungshilfe. (Quelle: Text Verlagseinband / Verlag)

As part of its review of competition law that started in the late 1990s, the European Commission proposes to revise its interpretation and application of the Treaty's prohibition of abuses of dominant positions. This volume includes chapters which critically appraise the Commission's proposals